Genotype-phenotype correlations in SCN8A -related disorders reveal prognostic and therapeutic implications Short SCN8A -related genotype-phenotype correlations
暂无分享,去创建一个
Ethan M. Goldberg | Zara | Silvana | J. Howe | P. May | T. Mayer | P. Striano | J. Verhoeven | H. Lerche | J. Rho | G. Rubboli | D. Wieczorek | Manuela Pendziwiat | I. Helbig | H. Bassan | U. Hedrich | E. Gardella | I. Borggraefe | K. Štěrbová | I. Kanivets | B. Gérard | R. Guerrini | M. Abramov | S. Sartori | A. Poduri | P. Veggiotti | D. Lal | M. Motazacker | K. Helbig | M. S. Perry | L. Canafoglia | F. Bilan | D. Lederer | M. Gérard | Tobias | K. Howell | D. Hoffman-Zacharska | J. Lemke | C. Marini | J. Savatt | G. Lesca | A. Roubertie | K. Wain | I. Krey | M. Koko | M. Meuwissen | R. Leventer | J. Rebstock | J. Schubert | A. Berger | S. Ruf | M. Buzatu | M. Alber | B. Zwaag | C. Fenger | M. Vlčková | P. Laššuthová | P. Accorsi | L. Giordano | H. Olson | R. S. Møller | W. Fazeli | S. Matricardi | A. Jansen | K. Johannesen | Wen‐Han Tan | P. Zacher | F. Darra | S. Ichikawa | S. Masnada | C. Betzler | M. Nizon | Nancy Eisenhauer | Ahmed Eltokhi | H. Verhelst | M. Nassogne | E. Scalais | Mastrangelo | C. Hoei-Hansen | Jan Benda | M. Koch-Hogrebe | J. Kegele | Tobias Brünger | T. Roser | S. Grønborg | A. Schoonjans | J. Krüger | P. Lakeman | A. V. Harder | D. Tibussek | P. Gélisse | E. Dadali | S. Korostelev | S. Lauxmann | Massimo | Federico | C. Altuzarra | M. Vaccarezza | Jakob Christensen | Karen | Lukas | A. Borovikov | Monisa Wagner | C. Lund | Yuanyuan Liu | Cathrine E. Gjerulfsen | Sonnenberg | Maert Rannap | A. Nils | Koch | Franceschetti | Pia Zacher | Constanze Heine | Judith Kroell-Seger | Karli M Martin | Klein | P. Au | A. Ho | Eva | Brilstra | Sebastian Lebon | N. M. Le | Mette U Schmidt-Petersen | Stephen W Scherer | Chloé | Stutterd | S. Walsh | M. Claudia | Bonardi | A. Vøllo | Roseline Caume | Artém | Sharkov | I. Mishina | Sergey | Kutsev | Müller-Schlüter | Anne | Destrée | Siddharth Srivastava | Loddenkemper | P. Mark | Fitzgerald | M. Perry | Johannes Rebstock | S. Lebon | Cathrine E Gjerulfsen | Rikke S. Møller | Phillis Lakeman | Dennis Lal | Monisa D. Wagner
[1] Jen Q. Pan,et al. Biological concepts in human sodium channel epilepsies and their relevance in clinical practice , 2020, Epilepsia.
[2] S. Antonarakis,et al. SCN8A heterozygous variants are associated with anoxic‐epileptic seizures , 2020, American journal of medical genetics. Part A.
[3] W. Gaillard,et al. A multi-disciplinary clinic for SCN8A-related epilepsy , 2019, Epilepsy Research.
[4] T. Cummins,et al. Distinct functional alterations in SCN8A epilepsy mutant channels , 2019, The Journal of physiology.
[5] Jacy L. Wagnon,et al. Biallelic inherited SCN8A variants, a rare cause of SCN8A‐related developmental and epileptic encephalopathy , 2019, Epilepsia.
[6] S. Julia,et al. Clinical study of 19 patients with SCN8A‐related epilepsy: Two modes of onset regarding EEG and seizures , 2019, Epilepsia.
[7] C. Zucca,et al. Novel epilepsy phenotype associated to a known SCN8A mutation , 2019, Seizure.
[8] H. Lerche,et al. Neuronal mechanisms of mutations in SCN8A causing epilepsy or intellectual disability , 2019, Brain : a journal of neurology.
[9] Jacy L. Wagnon,et al. Prominent role of forebrain excitatory neurons in SCN8A encephalopathy , 2019, Brain : a journal of neurology.
[10] Michael R. Johnson,et al. Ultra-rare genetic variation in the epilepsies: a whole-exome sequencing study of 17,606 individuals , 2019, bioRxiv.
[11] H. Lerche,et al. Relationship of electrophysiological dysfunction and clinical severity in SCN2A‐related epilepsies , 2018, Human mutation.
[12] I. Scheffer,et al. The phenotype of SCN8A developmental and epileptic encephalopathy , 2018, Neurology.
[13] Y. Yanagawa,et al. Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice , 2018, Communications Biology.
[14] I. Scheffer,et al. Early mortality in SCN8A-related epilepsies , 2018, Epilepsy Research.
[15] Christopher H. Thompson,et al. The novel sodium channel modulator GS‐458967 (GS967) is an effective treatment in a mouse model of SCN8A encephalopathy , 2018, Epilepsia.
[16] Jacy L. Wagnon,et al. Partial loss‐of‐function of sodium channel SCN8A in familial isolated myoclonus , 2018, Human mutation.
[17] Ryan L. Collins,et al. An analytical framework for whole-genome sequence association studies and its implications for autism spectrum disorder , 2018, Nature Genetics.
[18] Ji Yoon Han,et al. A Novel Inherited Mutation of SCN8A in a Korean Family with Benign Familial Infantile Epilepsy Using Diagnostic Exome Sequencing. , 2017, Annals of clinical and laboratory science.
[19] M. Meisler,et al. Severe bone loss and multiple fractures in SCN8A-related epileptic encephalopathy. , 2017, Bone.
[20] Liping Wei,et al. SCN8A mutations in Chinese patients with early onset epileptic encephalopathy and benign infantile seizures , 2017, BMC Medical Genetics.
[21] Jacy L. Wagnon,et al. Loss-of-function variants of SCN8A in intellectual disability without seizures , 2017, Neurology: Genetics.
[22] L. Lagae,et al. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders , 2017, Brain : a journal of neurology.
[23] Edouard Hirsch,et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology , 2017, Epilepsia.
[24] J. H. Cross,et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology , 2017, Epilepsia.
[25] John R. Huguenard,et al. Regulation of Thalamic and Cortical Network Synchrony by Scn8a , 2017, Neuron.
[26] A. Orsini,et al. Autosomal dominant SCN8A mutation with an unusually mild phenotype. , 2016, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[27] B. Steinhoff,et al. Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation , 2016, Annals of neurology.
[28] D. Valle,et al. GeneMatcher: A Matching Tool for Connecting Investigators with an Interest in the Same Gene , 2015, Human mutation.
[29] D. Lindhout,et al. Erratum to: Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach , 2015, Neurotherapeutics.
[30] D. Lindhout,et al. Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach , 2015, Neurotherapeutics.
[31] Jacy L. Wagnon,et al. Recurrent and Non-Recurrent Mutations of SCN8A in Epileptic Encephalopathy , 2015, Front. Neurol..
[32] Allan Bayat,et al. The incidence of SCN1A‐related Dravet syndrome in Denmark is 1:22,000: A population‐based study from 2004 to 2009 , 2015, Epilepsia.
[33] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[34] Yuehua Zhang,et al. SCN8A mutations in Chinese children with early onset epilepsy and intellectual disability , 2015, Epilepsia.
[35] S. Dib-Hajj,et al. De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy , 2015, Journal of Medical Genetics.
[36] G. Carvill,et al. The phenotypic spectrum of SCN8A encephalopathy , 2015, Neurology.
[37] M. Kals,et al. De Novo SCN8A Mutation Identified by Whole-Exome Sequencing in a Boy With Neonatal Epileptic Encephalopathy, Multiple Congenital Anomalies, and Movement Disorders , 2014, Journal of child neurology.
[38] Stef van Lieshout,et al. Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy , 2014, Epilepsy Research.
[39] M. Hammer,et al. A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy , 2014, Neurobiology of Disease.
[40] E. Leshinsky‐Silver,et al. Early onset epileptic encephalopathy caused by de novo SCN8A mutations , 2014, Epilepsia.
[41] K. Veeramah,et al. De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. , 2012, American journal of human genetics.
[42] A. Becker,et al. Molecular correlates of age-dependent seizures in an inherited neonatal-infantile epilepsy. , 2010, Brain : a journal of neurology.
[43] W. Frankel,et al. Heterozygous mutations of the voltage-gated sodium channel SCN8A are associated with spike-wave discharges and absence epilepsy in mice , 2009, Human molecular genetics.
[44] J. Trimmer,et al. Localization and targeting of voltage-dependent ion channels in mammalian central neurons. , 2008, Physiological reviews.
[45] Hiroyuki Miyamoto,et al. Nav1.1 Localizes to Axons of Parvalbumin-Positive Inhibitory Interneurons: A Circuit Basis for Epileptic Seizures in Mice Carrying an Scn1a Gene Mutation , 2007, The Journal of Neuroscience.
[46] W. Spain,et al. Erratum: Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy (Nature Neuroscience (2006) 9, (1142-1149)) , 2007 .
[47] Massimo Mantegazza,et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy , 2006, Nature Neuroscience.
[48] M. Meisler,et al. Heterozygosity for a protein truncation mutation of sodium channel SCN8A in a patient with cerebellar atrophy, ataxia, and mental retardation , 2005, Journal of Medical Genetics.
[49] A. L. Goldin,et al. A mutation that causes ataxia shifts the voltage-dependence of the Scn8a sodium channel. , 1999, Neuroreport.
[50] A. L. Goldin,et al. A Missense Mutation in the Sodium Channel Scn8a Is Responsible for Cerebellar Ataxia in the Mouse Mutant jolting , 1996, The Journal of Neuroscience.
[51] J. Court,et al. Physiological and biochemical studies on the cerebellar cortex of the murine mutants “jolting” and “motor end-plate disease” , 1992, Journal of the Neurological Sciences.
[52] J. Harris,et al. A CEREBELLAR ABNORMALITY IN THE MOUSE WITH MOTOR END‐PLATE DISEASE , 1985, Neuropathology and applied neurobiology.